(1. 上海市计划生育科学研究所药理毒理学研究室,中国生育调节药物毒理检测中心;2. 复旦大学生殖与发育研究院;3. 国家人口和计划生育委员会计划生育药具重点实验室,上海 200032)
R-33
WANG Liping
1. Department of Pharmcology and Toxicology, Shanghai Institute of Planned Parenthood Research,National Evaluation Center for Toxicology of Fertility Regulating Drugs; 2. Reproductive and Developmental Research Institute of Fudan University; 3. Key Laboratory of Reproduction Regulation of NPFPC,Shanghai 200032, ChinaSUN Zuyue
1. Department of Pharmcology and Toxicology, Shanghai Institute of Planned Parenthood Research,National Evaluation Center for Toxicology of Fertility Regulating Drugs; 2. Reproductive and Developmental Research Institute of Fudan University; 3. Key Laboratory of Reproduction Regulation of NPFPC,Shanghai 200032, China(1. Department of Pharmcology and Toxicology, Shanghai Institute of Planned Parenthood Research,National Evaluation Center for Toxicology of Fertility Regulating Drugs; 2. Reproductive and Developmental Research Institute of Fudan University; 3. Key Laboratory of Reproduction Regulation of NPFPC,Shanghai 200032, China)
王莉萍,孙祖越.抗氧化剂拮抗子宫内膜异位症的研究进展[J].中国比较医学杂志,2019,29(10):131~135.
复制